Literature DB >> 24846331

Clinical trials: Human antibody-mediated T-cell suppression for kidney transplantation.

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24846331     DOI： 10.1038/nrneph.2014.82

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection.

Authors:  S M Flechner; S Mulgoankar; L B Melton; T H Waid; A Agarwal; S D Miller; F Fokta; M T Getts; T J Frederick; J J Herrman; J P Puisis; L O'Toole; R Sung; F Shihab; A C Wiseman; D R Getts
Journal:  Am J Transplant       Date:  2014-04-17       Impact factor: 8.086
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.